Global Drug Delivery Devices Market size is expected to be worth around US$ 862.16 Billion by 2034 from US$ 410.61 Billion in 2024.

Connected Drug Delivery Devices Market Report is Segmented by Product Type(Connected Sensors [Connected Inhaler Sensors and More] and Integrated Connected Devices [Connected Inhalers and More), Technology (Bluetooth, Near-Field Communication and More), End User (Healthcare Providers, Homecare and More), Application (Respiratory Diseases, Diabetes and More) and Geography. The Market Forecasts are Provided in Terms of Value (USD).

The global drug delivery devices market size was USD 280.98 billion in 2024 & is projected to grow from USD 296.60 billion in 2025 to USD 482.69 billion by 2033.
Report Scope:

The global drug delivery devices market size was valued at over USD 422.72 billion in 2025 and is expected to expand at a CAGR of around 7.1%, surpassing USD 839.36 billion revenue by 2035, driven by the swift COVID-19 vaccination drive globally.

Snapshot img

Drug Delivery Devices Market Size 2024-2028

The drug delivery devices market size is forecast to increase by USD 85.1 billion at a CAGR of 6.2% between 2023 and 2028.

The market is experiencing significant growth due to the increasing prevalence of chronic conditions and the rising adoption of self-administering systems. Self-injectable devices, including auto-injectors and jet-injectors, are gaining popularity for their convenience and effectiveness in delivering drugs directly to the target site. However, bioavailability hurdles remain a challenge in oral delivery systems, leading to the increasing use of injectable routes. Pharmaceutical companies are investing heavily in research and development to address these challenges and create more efficient drug delivery systems.In healthcare, Retail pharmacies and hospital pharmacies are key distribution channels for these devices, ensuring easy access for patients. Stringent government regulations ensure the safety and efficacy of these devices, making them a reliable option for patients. The market is expected to continue growing as technology advances and new applications for drug delivery systems emerge.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

 The market represents a significant segment within the pharmaceutical industry, offering innovative solutions for the effective and efficient administration of active pharmaceutical ingredients (APIs) in various therapeutic areas. These devices cater to both chronic diseases and non-chronic diseases, and their usage extends to home-care environments, retail pharmacies, hospital pharmacies, and online pharmacies. Advanced technology plays a crucial role in the development of drug delivery devices. Next-generation technologies, such as self-administering systems, auto-injectors, pen injectors, jet-injectors, prefilled syringes, and smart sensors, have gained popularity due to their patient-friendly designs and improved accuracy. In the context of chronic diseases, drug delivery devices have proven to be essential for targeted medication delivery.
Biologics drugs, which often require specific delivery methods, have particularly benefited from these advancements. The pharmaceutical industry's focus on diagnosis and treatment has led to the integration of drug delivery devices in various vaccination drives and therapeutic areas. Oral drug delivery and injectable drug delivery systems have shown remarkable progress, offering enhanced patient compliance and convenience. Homecare solutions have emerged as a key area of growth within the market. These devices enable patients to administer medications in the comfort of their homes, reducing the need for frequent hospital visits and improving overall patient care.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Route Of Administration

  Oral
  Injectable
  Pulmonary
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia



  Rest of World (ROW)

By Route Of Administration Insights

The oral segment is estimated to witness significant growth during the forecast period.

The market for Drug Delivery Devices encompasses various types of devices used for administering drugs, including Injection Devices, Oral Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, and Nasal Drug Delivery. Among these, the segment for Oral Drug Delivery is significant due to its ease of use, non-invasive nature, and cost-effectiveness. This segment includes drugs in the form of capsules, tablets, syrups, solutions, and suspensions

Furthermore, orally administered drugs can be targeted to specific areas within the gastrointestinal tract to treat various conditions, including cancer, inflammation, infections, and bowel diseases. Advancements in pharmaceutical technologies and oral drug delivery systems, such as lipid-based carriers, nanocarriers, and micelles, are enhancing oral drug absorption, thereby improving therapeutic effectiveness. Hence, such factors are fuelling the growth of this segment during the forecast period.

Get a glance at the market report of share of various segments Request Free Sample

The oral segment was valued at USD 85.50 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 52% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The mar

Check Market Research Intellect's Drug Delivery Devices Market Report, pegged at USD 165 billion in 2024 and projected to reach USD 280 billion by 2033, advancing with a CAGR of 7.4% (2026-2033).Explore factors such as rising applications, technological shifts, and industry leaders.

Italy Drug Delivery Devices Market Report is Segmented by Device Type (Injectable Delivery Devices, Inhalation Delivery Devices, Infusion Pumps, and More), Route of Administration (Injectable, Inhalational, Transdermal Patches, Oral Mucosal and More), Application (Cancer, Cardiovascular, Diabetes and More), End User (Hospitals, Ambulatory Surgical Centers, and More). The Market and Forecasts are Provided in Terms of Value (USD).

The Drug Delivery Devices Market will grow from USD 261.32 Billion in 2024 to USD 412.66 Billion by 2030 at a 7.91% CAGR.

• The global industry was valued at US$ 390.7 Mn in 2023
• It is expected to grow at a CAGR of 6.8% from 2024 to 2034 and reach US$ 796.1 Mn by the end of 2034

On-body Drug Delivery Devices Market Overview

Regional Analysis of On-body Drug Delivery Devices Market

On-body Drug Delivery Devices Market Snapshot

Drug Delivery Device Market size is growing with a CAGR of 9.0% in the prediction period and it crossesUSD 419.14 Bn by 2032 from USD 229.14 Bn in 2025

Connected Drug Delivery Devices Market size is valued at USD 4.2 Billion in 2024 and is projected to reach USD 11 billion by 2030 with 17% CAGR [2025-2030]

Drug Delivery Devices Market size was valued at USD 2.13 Billion in 2022 and is projected to reach USD 7.96 Billion by 2030 growing at a CAGR of 16.27% From 2024-2030.The global Drug Delivery Devices Market is expanding primarily due to the increasing prevalence of the chronic disease across the globe. Due to lifestyle choices and lack of physical exercise, the cases of diabetes, cardiovascular diseases, and cancer have exponentially increased in the past decade. This has promoted the key players to launch innovative medications and invest heavily in R&D activities. Such developments have greatly propelled the market for drug-delivery devices. The leading market players are introducing innovative products that offer better drug efficacy while reducing side effects, which is expected to open many attractive opportunities during the forecast period.

The India Drug Delivery Devices Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 5.5% during the forecast period, 2023 – 2031. Growth of the market is attributed to the increasing funding from government & private organization, rising number of development & research activities, rise in technological advancement, and unhealthy lifestyle.

The delivery of a drug and therapeutic is done by specialized tools from a specific route of administration like drug delivery devices. As part of one & more medical treatments such devices are used.

The Covid-19 pandemic affected the demand and supply of India drug delivery devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

• 
  

  Technological advancement in device sector is projected to boost the market in the coming years.

  
  


• 
  

  Increasing number of diseases requiring drug delivery is the major factor fueling the market.

  
  


• 
  

  Rising risk of needlestick injuries is anticipated to restrict the market growth.</span&g

Drug Delivery Devices Market Size was USD 20.64 Billion in 2022 and is expected to register a rapid revenue CAGR of 8% during the forecast period.

The Global Injectable Drug Delivery Devices Market Size Was Worth USD 468 Billion in 2023 and Is Expected To Reach USD 577 Billion by 2032, CAGR of 6.7%.

Non-Invasive drug delivery devices market is segmented into products types, application. Market to grow at a CAGR of 23.13% during forecast period 2019 to 2025. Non-Invasive drug delivery devices market report by BIS Research provides deep market insight that will help your business to grow.

Learn more about the Connected Drug Delivery Devices Market Report by Market Research Intellect, which stood at USD 5.8 billion in 2024 and is forecast to expand to USD 15.2 billion by 2033, growing at a CAGR of 12.5%.Discover how new strategies, rising investments, and top players are shaping the future.

The Australia Drug Delivery Devices Market Report is Segmented by Device Type (Injectable Delivery Devices, Inhalation Delivery Devices, Infusion Pumps and More), Route of Administration (Injectable, Inhalational, Transdermal and More), Application (Cancer, Cardiovascular, Diabetes and More), End User (Hospitals, Ambulatory Surgical Centers, and More). The Market and Forecasts are Provided in Terms of Value (USD).

The global drug delivery systems market size was worth over USD 48.66 billion in 2025 and is poised to grow at a CAGR of around 6.1%, reaching USD 87.97 billion revenue by 2035, fueled by technological advancement and innovations in drug delivery systems.

The size of the United States Drug Delivery Devices Market market was valued at USD XX Million in 2024 and is projected to reach USD XXX Million by 2033, with an expected CAGR of 22.78% during the forecast period. Recent developments include: October 2022: FDA approved FUROSCIX (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for the treatment of congestion due to fluid overload in adults with New York Heart Association Class II/III chronic heart failure., September 2022: Baxter International Inc., received the US FDA approval for the commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine). Norepinephrine is used to increase blood pressure in adult patients who have severe, acute hypotension.. Key drivers for this market are: Growing Burden of Chronic Diseases, Innovation in Drug Delivery Devices. Potential restraints include: Product Recalls. Notable trends are: Cancer Segment is Expected to Hold a Major Market Share in the United States Drug Delivery Devices Market.